<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02346656</url>
  </required_header>
  <id_info>
    <org_study_id>15-SMI-2013</org_study_id>
    <nct_id>NCT02346656</nct_id>
  </id_info>
  <brief_title>a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin</brief_title>
  <acronym>BRAVO</acronym>
  <official_title>BRAVO: a BavaRiAn eValuatiOn of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      15-SMI-2013 is a post market, observational, questionnaire based study to assess the&#xD;
      effectiveness of the commercially available Axium neurostimulator in the management of&#xD;
      chronic post surgical groin pain&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inadequate Enrolment&#xD;
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Relief - Assessed by Change in Pain Intensity Assessed using a Visual Analogue Scale (VAS) from Pre-Treatment Baseline</measure>
    <time_frame>Post treatment at; 1 week and 1, 3, 6 and12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">7</enrollment>
  <condition>Post Surgical Groin Pain</condition>
  <arm_group>
    <arm_group_label>Treated subjects</arm_group_label>
    <description>All subjects recruited and treated with the Axium neurostimulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation with the commercially available Axium neurostimulator</intervention_name>
    <arm_group_label>Treated subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Post Surgical Groin Pain Patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patient is at least 18 years old&#xD;
&#xD;
          2. The patient is willing and able to comply with the examination schedule and the trial&#xD;
             schedule.&#xD;
&#xD;
          3. The patient has suffered from chronic post-surgical neuropathic groin pain for at&#xD;
             least 6 months&#xD;
&#xD;
          4. Conservative treatments of the chronic pain including medication, physiotherapy and&#xD;
             interventions have been exhausted&#xD;
&#xD;
          5. The pain level at the time of the baseline examination is at least 60mm on the visual&#xD;
             analogue scale (VAS) in the primary pain area (groin pain)&#xD;
&#xD;
          6. The patient is able to give consent in writing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or breastfeeding patients or those who plan to become pregnant during the&#xD;
             study&#xD;
&#xD;
          2. It has been established in an examination by the tester that the pain has&#xD;
             significantly worsened or changed its characteristics in the course of the previous&#xD;
             month.&#xD;
&#xD;
          3. In the last 30 days, the patient has been treated with corticosteroids on an area&#xD;
             scheduled for the stimulation.&#xD;
&#xD;
          4. In the last 3 months, the patient has been treated with radio frequency therapy on an&#xD;
             area scheduled for the stimulation.&#xD;
&#xD;
          5. The patient has already been treated with an active implantable device, including an&#xD;
             implantable cardioverter defibrillator, pacemaker, spinal cord stimulator or an&#xD;
             intrathecal medication pump.&#xD;
&#xD;
          6. The patient is not able to operate the stimulation device&#xD;
&#xD;
          7. The patient is currently suffering from an infection&#xD;
&#xD;
          8. The patient has participated in another clinical study in the last 30 days&#xD;
&#xD;
          9. The patient has a coagulation disorder or is taking anti-coagulants, which would make&#xD;
             participation impossible, as per the study doctor&#xD;
&#xD;
         10. The patient has been diagnosed with a malignancy in the past 2 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Algesiologikum Zentrum für Schmerzmedizin</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 9, 2015</study_first_submitted>
  <study_first_submitted_qc>January 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2015</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

